BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26360382)

  • 21. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.
    Mathalone N; Arodi-Golan A; Sar S; Wolfson Y; Shalem M; Lavi I; Geyer O
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1435-40. PubMed ID: 22434210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.
    Nariani A; Williams B; Hariprasad SM
    Indian J Ophthalmol; 2016 Sep; 64(9):643-647. PubMed ID: 27853011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab.
    Freund KB; Hoang QV; Saroj N; Thompson D
    Ophthalmology; 2015 Sep; 122(9):1802-10. PubMed ID: 26025097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry.
    Gabrielle PH; Nguyen V; Wolff B; Essex R; Young S; Hunt A; Gemmy Cheung CM; Arnold JJ; Barthelmes D; Creuzot-Garcher C; Gillies M;
    Ophthalmol Retina; 2020 Sep; 4(9):861-870. PubMed ID: 32574830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of multiple intravitreal antivascular endothelial growth factor injections on intraocular pressure.
    Kim YJ; Sung KR; Lee KS; Joe SG; Lee JY; Kim JG; Yoon YH
    Am J Ophthalmol; 2014 Jun; 157(6):1266-1271.e1. PubMed ID: 24561173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.
    Yannuzzi NA; Patel SN; Bhavsar KV; Sugiguchi F; Freund KB
    Am J Ophthalmol; 2014 Aug; 158(2):319-327.e2. PubMed ID: 24814167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells.
    Park J; Lee M
    BMC Ophthalmol; 2018 Jan; 18(1):17. PubMed ID: 29368595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.
    Fuest M; Kotliar K; Walter P; Plange N
    Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glaucoma Tube Outcomes with and without Anti-VEGF in Patients with Age-related Macular Degeneration.
    Rothman AL; Beca FA; Tijerina JD; Schuman DM; Parrish RK; Vanner EA; Liu KC
    Ophthalmol Glaucoma; 2024; 7(3):260-270. PubMed ID: 38266962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short term effects of intravitreal anti-vascular endothelial growth factor agents on cornea, anterior chamber, and intraocular pressure.
    Arslan GD; Guven D; Alkan AA; Kacar H; Demir M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):344-348. PubMed ID: 31092017
    [No Abstract]   [Full Text] [Related]  

  • 33. Short-term intraocular pressure changes after intravitreal injection of bevacizumab.
    Hollands H; Wong J; Bruen R; Campbell RJ; Sharma S; Gale J
    Can J Ophthalmol; 2007 Dec; 42(6):807-11. PubMed ID: 18026202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Jo YJ; Kim WJ; Shin IH; Kim JY
    Korean J Ophthalmol; 2016 Apr; 30(2):114-20. PubMed ID: 27051259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
    J Glaucoma; 2012; 21(4):241-7. PubMed ID: 21423038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Effect of Anti-VEGF Agents on Intraocular Pressure in Age-Related Macular Degeneration.
    Beato J; Pedrosa AC; Pinheiro-Costa J; Freitas-da-Costa P; Falcão MS; Melo A; Estrela-Silva S; Falcão-Reis F; Carneiro ÂM
    Ophthalmic Res; 2016; 56(1):30-4. PubMed ID: 27046391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M; Vu L; Whitson JT; He YG
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of axial length and postinjection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Jung JJ; Mrejen S; Freund KB
    Retina; 2014 Mar; 34(3):519-24. PubMed ID: 24240557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis.
    Nanji K; Sarohia GS; Kennedy K; Ceyhan T; McKechnie T; Phillips M; Devji T; Thabane L; Kaiser P; Sarraf D; Garg SJ; Sivaprasad S; Wykoff CC; Bakri SJ; Sheidow T; Bhandari M; Chaudhary V
    Ophthalmology; 2022 May; 129(5):498-508. PubMed ID: 34871637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent elevation of intraocular pressure following intravitreal injection of bevacizumab.
    Segal O; Ferencz JR; Cohen P; Nemet AY; Nesher R
    Isr Med Assoc J; 2013 Jul; 15(7):352-5. PubMed ID: 23943979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.